retatrutide clinical trial parkinson Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Retatrutide produces up to 30.3%

The FDA approved a GLP-1 pill from Eli Lilly called Foundayo

Precision medicine approaches that leverage patient-specific markers offer a promising strategy to improve therapeutic outcomes

The injectable drug, initially only used as diabetes medication, is the first drug since Saxenda (2014) approved to treat chronic weight management in the 70% of American adults who are obese or overweight.

Nutritionist Leyla Muedin shares the benefits and drawbacks of increasingly popular GLP-1 weight loss drugs.

The bundle focuses on high-protein meals, balanced food choices, hydration, gentle nutrition, and easy wellness routines to help make everyday life feel more manageable